Patti Giuseppe, Di Sciascio Germano
Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
Intern Emerg Med. 2009 Jun;4(3):201-11. doi: 10.1007/s11739-008-0220-5. Epub 2009 Jan 8.
In this paper, data from available studies regarding some contemporary issues on clopidogrel therapy are analyzed. In particular, the following clinical questions have been considered and addressed: (a) Is early clopidogrel treatment needed in patients with acute coronary syndromes treated medically or undergoing percutaneous coronary intervention (PCI)? (b) What is the optimal clopidogrel loading dose in patients undergoing PCI? (c) Is pre-treatment with clopidogrel before PCI needed, or can clopidogrel loading be given in the catheter laboratory before intervention, but after coronary anatomy is known? (d) What is the optimal clopidogrel strategy in patients on chronic clopidogrel therapy undergoing PCI? (e) Does the degree of clopidogrel response influence clinical outcome in patients undergoing PCI?
本文分析了有关氯吡格雷治疗一些当代问题的现有研究数据。具体而言,已考虑并探讨了以下临床问题:(a)接受药物治疗或经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征患者是否需要早期氯吡格雷治疗?(b)接受PCI的患者最佳氯吡格雷负荷剂量是多少?(c)PCI前是否需要氯吡格雷预处理,还是可以在介入前但在知晓冠状动脉解剖结构后在导管室给予氯吡格雷负荷剂量?(d)接受PCI的慢性氯吡格雷治疗患者的最佳氯吡格雷策略是什么?(e)氯吡格雷反应程度是否会影响接受PCI患者的临床结局?